The landscape of designing and conducting clinical trials has exhibited limited evolution in the past two decades. Typically, biopharmaceutical companies have outsourced their trial operations to a solitary contract research organization (CRO), which assumes responsibility for overseeing various trial components, encompassing data collection and administration. While this conventional approach isn't inherently flawed, there exist notable advantages in engaging a Biometrics CRO in conjunction with your Clinical CRO collaborator, particularly in the realm of data management.
This white paper examines the merits associated with the strategic pairing of two distinct CROs: one focused on clinical requirements and the other specialized in biometrics. In the ensuing sections, the authors elucidate five pivotal benefits stemming from this collaborative strategy.